Pharma Executive Faints Behind Trump in Oval Office Event
A pharmaceutical executive fainted in the Oval Office during a weight-loss medication announcement involving the Trump administration. The incident occurred on Thursday, with the executive identified as Gordon Findlay from Novo Nordisk.
Details of the Incident
Findlay collapsed while standing behind President Trump. Witnesses reported that his knees buckled unexpectedly. Dr. Mehmet Oz, the Administrator for the Centers for Medicare & Medicaid Services, acted swiftly to assist him.
Immediate Response
- Dr. Oz helped Findlay to the ground to prevent a potential injury.
- Cabinet members attended to him promptly by elevating his legs.
- The White House Medical Unit was on hand and responded quickly to the situation.
Official Statements
White House Press Secretary Karoline Leavitt provided an update following the incident. She confirmed that the executive received immediate care and that he is okay. Leavitt stated, “During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The Press Conference will resume shortly.”
Conclusion
This unforeseen event occurred amidst significant discussions regarding new deals for weight-loss medications. The quick actions of those present ensured that Findlay received the necessary help, highlighting the readiness of medical personnel at the White House.
